...
机译:高剂量甲氨蝶呤巩固治疗低危儿童急性淋巴细胞白血病的个体化毒性滴定的6-巯基嘌呤增量。北欧儿科血液和肿瘤学会(NOPHO)初步研究
Department of Paediatrics Rigshospitalet Copenhagen Denmark;
Department of Paediatrics Queen Silvias Childrens Hospital Gothenburg Sweden;
Department of Paediatrics University of Tampere Finland;
Department of Paediatrics University Hospitals Astrid Lindgrens Barnsjukhus Stockholm Sweden;
Department of Paediatrics University Hospital Linköping Linköping Sweden;
Department of Paediatrics Lund University Hospital Lund Sweden;
Department of Paediatrics Syddanmarks University Hospital Odense Denmark;
Department of Paediatrics University Hospital of Uppsala Uppsala Sweden;
Department of Biostatistics University of Copenhagen;
The Institute of Gynecology Obstetrics and Paediatrics The Faculty of Medicine University of Copenhagen Copenhagen Denmark;
acute lymphoblastic leukaemia; chemotherapy; children; consolidation; purine analogues;
机译:高剂量甲氨蝶呤巩固治疗低风险儿童急性淋巴细胞白血病的个体化毒性滴定的6-巯基嘌呤增量。北欧儿科血液学和肿瘤学协会(NOPHO)初步研究。
机译:患儿童急性淋巴细胞白血病的合并治疗中的个性化的6-巯基嘌呤:Nopho随机对照试验
机译:患儿童急性淋巴细胞白血病的合并治疗中的个性化的6-巯基嘌呤:Nopho随机对照试验
机译:临床试验和观察:甲氨蝶呤/ 6-巯基嘌呤维持治疗影响儿童急性淋巴细胞白血病后继发恶性肿瘤的风险:NOPHO ALL-92研究的结果
机译:高剂量甲氨蝶呤巩固治疗低危儿童急性淋巴细胞白血病的个体化毒性滴定的6-巯基嘌呤增量。北欧儿科血液和肿瘤学会(NOPHO)初步研究